BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10531149)

  • 1. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision.
    Gu YJ; Mariani MA; Boonstra PW; Grandjean JG; van Oeveren W
    Chest; 1999 Oct; 116(4):892-8. PubMed ID: 10531149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass.
    Strüber M; Cremer JT; Gohrbandt B; Hagl C; Jankowski M; Völker B; Rückoldt H; Martin M; Haverich A
    Ann Thorac Surg; 1999 Oct; 68(4):1330-5. PubMed ID: 10543502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.
    Tárnok A; Hambsch J; Emmrich F; Sack U; van Son J; Bellinghausen W; Borte M; Schneider P
    Pediatr Cardiol; 1999; 20(2):113-25. PubMed ID: 9986887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery.
    Pągowska-Klimek I; Świerzko AS; Michalski M; Głowacka E; Szala-Poździej A; Sokołowska A; Moll M; Krajewski WR; Romak J; Cedzyński M
    Clin Exp Immunol; 2016 May; 184(2):257-63. PubMed ID: 26703090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass.
    Diegeler A; Doll N; Rauch T; Haberer D; Walther T; Falk V; Gummert J; Autschbach R; Mohr FW
    Circulation; 2000 Nov; 102(19 Suppl 3):III95-100. PubMed ID: 11082370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How safe is the port access technique in minimally invasive coronary artery bypass grafting?
    Dogan S; Graubitz K; Aybek T; Khan MF; Kessler P; Moritz A; Wimmer-Greinecker G
    Ann Thorac Surg; 2002 Nov; 74(5):1537-43; discussion 1543. PubMed ID: 12440605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
    van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery.
    Nair S; Iqbal K; Phadke M; Jadhav UE; Khandekar J; Khandeparkar JM
    J Postgrad Med; 2012; 58(1):8-13. PubMed ID: 22387642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and neutrophil activation during cardiopulmonary bypass: a randomized comparison of hypothermic and normothermic circulation.
    Chello M; Mastroroberto P; Romano R; Ascione R; Pantaleo D; De Amicis V
    Eur J Cardiothorac Surg; 1997 Jan; 11(1):162-8. PubMed ID: 9030806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting.
    Gu YJ; Mariani MA; van Oeveren W; Grandjean JG; Boonstra PW
    Ann Thorac Surg; 1998 Feb; 65(2):420-4. PubMed ID: 9485239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: does it exist?
    Tassani P; Schad H; Winkler C; Bernhard A; Ettner U; Braun SL; Eising GP; Kochs E; Lange R; Richter JA
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):735-41. PubMed ID: 11986602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Fitch JC; Rollins S; Matis L; Alford B; Aranki S; Collard CD; Dewar M; Elefteriades J; Hines R; Kopf G; Kraker P; Li L; O'Hara R; Rinder C; Rinder H; Shaw R; Smith B; Stahl G; Shernan SK
    Circulation; 1999 Dec 21-28; 100(25):2499-506. PubMed ID: 10604887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass.
    Czerny M; Baumer H; Kilo J; Lassnigg A; Hamwi A; Vukovich T; Wolner E; Grimm M
    Eur J Cardiothorac Surg; 2000 Jun; 17(6):737-42. PubMed ID: 10856869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
    Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
    Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of PMEA-coated bypass circuits on perioperative inflammatory response.
    Ninomiya M; Miyaji K; Takamoto S
    Ann Thorac Surg; 2003 Mar; 75(3):913-7; discussion 917-8. PubMed ID: 12645716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit?
    Abdel-Rahman U; Ozaslan F; Risteski PS; Martens S; Moritz A; Al Daraghmeh A; Keller H; Wimmer-Greinecker G
    Ann Thorac Surg; 2005 Jul; 80(1):238-43. PubMed ID: 15975373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin and complement activation during major operations with or without cardiopulmonary bypass.
    Garred P; Fosse E; Fagerhol MK; Videm V; Mollnes TE
    Ann Thorac Surg; 1993 Mar; 55(3):694-9. PubMed ID: 8452432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.